Adrenomedullin: A cardiac depressant factor in septic shock

Journal of Cardiac Surgery

Volumn 17, Issue 4, 2001, Pages 328-335

  Hyvelin, Jean Marc ^a   Shan, Qixian ^b   Bourreau, Jean Pierre ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CYTOKINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; CELL FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; HEART CONTRACTION; HEART VENTRICLE FAILURE; HYPOTENSION; INTENSIVE CARE; MALE; MUSCLE CELL; NONHUMAN; RAT; SEPSIS; SEPTIC SHOCK;

EID: 12244298914     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb01152.x     Document Type: Conference Paper

References (26)

1. Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;261:S64-S74.
2. Balk RA: Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000;16(2):179-192.
3. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-242.
4. Lefer AM: Endotoxin, cytokines, and nitric oxide in shock. Shock 1994;1:79-80.
5. Rees DD, Monkhouse JE, Cambridge D, et al: Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol 1998;124:540-546.
6. Gardiner SM, March JE, Kemp PA, et al: Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats. Br J Pharmacol 1999;127:1611-1618.
7. Shan Q, Bourreau JP: Cardiac and vascular effects of nitric oxide synthase inhibition in lipopolysaccharide-treated rats. Eur J Pharmacol 2000;406(2):257-264.
8. Balligand JL: Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 1999; 43:607-620.
9. Klabunde RE, Coston AF: Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 1995;3:73-78.
10. Laubach VE, Shesely EG, Smithies O, et al: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995;92:10688-10692.
11. Shoji H, Minamino N, Kangawa K, et al: Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995;215:531-537.
12. Zhou M, Chaudry IH, Wang P: Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis. Biochim Biophys Acta 1999;1453:273-283.
13. Kitamura K, Kangawa, Kawamoto M, et al: Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-560.
14. Hwang IS, Tang F: Peripheral distribution and gene expression of adrenomedullin in the rat: Possible source of blood adrenomedullin. Neuropeptides 2000;34:32-37.
15. Ihara T, Ikeda U, Tate Y, et al: Positive inotropic effects of adrenomedullin on rat papillary muscle. Eur J Pharmacol 2000;390:167-172.
16. Saetrum OO, Hasbak P, de Vries R, et al: Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. Eur J Pharmacol 2000;397(2-3):373-382.
17. Saetrum OO, de Vries R, Tom B, et al: Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium. Eur J Pharmacol 1999;385:147-154.
18. Szokodi I, Kinnunen P, Tavi P, et al: Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998;197:1062-1070.
19. Nishikimi T, Horio T, Yoshihara F, et al: Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 1998;353:337-344.
20. Perret M, Broussard H, LeGros T, et al: The effect of adrenomedullin on the isolated heart. Life Sci 1993;53:L377-L379.
21. Ikenouchi H, Kangawa K, Matsuo H, et al: Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation 1997;95:2218-2324.
22. Sakata J, Shimokubo T, Kitamura K, et al: Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993;195:921-927.
23. Turcato S, Clapp LH: Effects of the adenylyl cyclase inhibitor SQ22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta. Br J Pharmacol 1999;126:845-847.
24. Iwasaki H, Eguchi S, Shichiri M, et al: Down-regulation of adenylate cyclase coupled to adrenomedullin receptor in vascular smooth muscle cells. Eur J Pharmacol 1998;352:131-134.
25. Vila-Petroff MG, Younes A, Egan J, et al: Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999;84:1020-1031.
26. Shindo T, Kurihara H, Maemura K, et al: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000;101:2309-2316.